DERIVAŢI DE BENZENSULFONAMIDĂ, PROCEDEU DE PREPARARE A ACESTORA, COMPOZIŢIE FARMACEUTICĂ ŞI UTILIZAREA CA INHIBITORI DE COX-2

Price not visible for this package

Interest:

Assignment

Publication info:

No.: RO121338

Date: 30.03.2007

Inventor(s):

TALLEY JOHN J [US]

MALECHA JAMES W [US]

BERTENSHAW STEPHEN [US]

GRANETO MATTHEW J [US]

CARTER JEFFERY S [US]

LI JINGLIN [US]

NAGARAJAN SRINIVASAN [US]

BROWN DAVID L [US]

ROGIER DONALD J JR [US]

PENNING THOMAS D [US]

KHANNA ISH K [US]

XU XIANGDONG [US]

WEIER RICHARD M [US]

Applicant(s):
SEARLE & CO [US]
Classification:
International patent classification (IPC):
A61K31/00; A61K31/18; A61K31/34; A61K31/341; A61K31/365; A61K31/40; A61K31/415; A61K31/4162; A61K31/4164; A61K31/42; A61K31/421; A61K31/44; A61K31/4427; A61K31/4439; A61K31/635; A61P1/02; A61P1/04; A61P11/02; A61P11/06; A61P11/08; A61P13/12; A61P15/06; A61P17/02; A61P17/04; A61P17/06; A61P19/02; A61P19/08; A61P21/00; A61P21/04; A61P25/00; A61P25/04; A61P25/28; A61P27/02; A61P27/12; A61P29/00; A61P29/02; A61P3/10; A61P31/12; A61P35/00; A61P37/00; A61P43/00; A61P5/16; A61P7/06; A61P9/10; C07C311/16; C07C311/39; C07C311/51; C07D207/32; C07D207/327; C07D207/33; C07D231/12; C07D233/54; C07D233/62; C07D233/64; C07D261/08; C07D263/32; C07D307/46; C07D307/58; C07D401/04; C07D417/04; C07D495/04; C07D331/00; C07D335/00; C07D

Cooperative patent classification (CPC):
A61K31/18 (EP, US); A61K31/415 (EP, US); A61K31/42 (EP, KR, US); A61K31/635 (EP, US); A61P1/02 (EP); A61P1/04 (EP); A61P11/02 (EP); A61P11/06 (EP); A61P11/08 (EP); A61P13/12 (EP); A61P15/06 (EP); A61P17/02 (EP); A61P17/04 (EP); A61P17/06 (EP); A61P19/02 (EP); A61P19/08 (EP); A61P21/00 (EP); A61P21/04 (EP); A61P23/00 (EP); A61P25/00 (EP); A61P25/04 (EP); A61P25/06 (EP); A61P25/28 (EP); A61P27/02 (EP); A61P27/12 (EP); A61P29/00 (EP); A61P29/02 (EP); A61P3/10 (EP); A61P31/12 (EP); A61P35/00 (EP); A61P37/00 (EP); A61P43/00 (EP); A61P5/16 (EP); A61P7/06 (EP); A61P9/10 (EP); C07C311/16 (EP, US); C07C311/39 (KR); C07C311/51 (EP, US); C07D207/33 (EP, US); C07D231/12 (EP, US); C07D233/64 (EP, US); C07D261/08 (EP, KR, US); C07D263/32 (EP, US); C07D307/58 (EP, US); C07D401/04 (EP, US); C07D417/04 (EP, US); C07D495/04 (EP, US); C07C2601/10 (EP, US)
Application info:
No.: RO19980001469
Date: 11.04.1997
Priority number(s):
US19960631514 12.04.1996 ; WO1997US05497 11.04.1997
Related patents:
AP1009; ATE233743; ATE408607; AU2722797; AU734275; BG102916; BG109057; BG64531; BR1100403; BR9708574; CA2249009; CN1098256; CN1216043; CU23116; CZ271098; CZ297430; DE69719496; DK0892791; DK1288206; EA003319; EA199800919; EE03685; EE9800351; EP0892791; EP1288206; ES2194195; ES2311571; GEP20032998; HK1019741; HU225473; HU9901807; IL125849; IL153738; IS2156; IS4863; IS7292; JP2000509029; JP2003160554; JP3382624; JP4049307; KR100387658; KR20000005395; LT4586; LT98142; LV12239; ME00768; NO314184; NO984727; NZ331542; OA11015; PL195955; PL329276; PT1288206; PT892791; RS50019; SI22713; SI9720035; SK124298; SK285353; TR199802049; TW585857; UA47475; US2003069287; US2005032851; US5932598; US6436967; US6815460; US7420061; WO9738986; YU44398; ZA973146
Description:

Invenţia de faţă se referă la agenţi farmaceutici antiinflamatori ?i în mod specific se referă la precursori medicamento?i ai compu?ilor care inhibă în mod selectiv ciclooxigenaza-2, cu formula generală IIla procedee de preparare a acestora, compoziţii farmaceutice care îi conţin ?i la utilizarea ca inhibitori de COX-2, pentru prepararea unui medicament pentru tratamentul inflamaţiei sau al unei afecţiuni asociate cu inflamaţia.

cover